The University of Chicago Header Logo

Connection

Pankti Reid to C-Reactive Protein

Back to Details
This is a "connection" page, showing publications Pankti Reid has written about C-Reactive Protein.
Pankti Reid
Connection Strength
0.688
C-Reactive Protein
  1. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
    View in: PubMed
    Score: 0.688
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.